NCT06526494View on ClinicalTrials.gov

Metformin and Vascular Function in Prediabetes

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2026

Conditions
PreDiabetes
Interventions
DRUG

Metformin

Oral ingestion for 12 weeks

OTHER

Placebo

Oral placebo for 12 weeks

Trial Locations (2)

52242

RECRUITING

University of Iowa, Iowa City

52245

RECRUITING

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
lead

Diana Jalal

OTHER

NCT06526494 - Metformin and Vascular Function in Prediabetes | Biotech Hunter | Biotech Hunter